Literature DB >> 12141975

Infantile pertussis rediscovered in China.

Jingmin Wang1, Yonghong Yang, Jie Li, Jussi Mertsola, Heikki Arvilommi, Xuzhuang Shen, Qiushui He.   

Abstract

Immunization against pertussis was introduced in China in the 1960s. Since the 1970s, no culture-confirmed pertussis cases have been reported in the country. We report six infants with culture-confirmed pertussis, who were initially diagnosed as having other respiratory diseases at Beijing Children's Hospital, Beijing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12141975      PMCID: PMC2732523          DOI: 10.3201/eid0808.010442

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Immunization against pertussis was begun in China in the 1960s. Three doses of whole cell pertussis vaccine combined with diphtheria and tetanus toxoids are given at 3, 4, and 5 months of age (1). Since 1982, a booster dose has been added, given at 18–24 months of age (1). In the 1990s, >85% of children received at least three doses of vaccine, and the incidence of pertussis (based on clinical diagnosis) remained <1/100,000 population (1). In China, pertussis is a reportable infectious disease, diagnosed by physicians. Since the 1970s, no culture-confirmed pertussis cases have been reported in the country. However, during April–June 1997, a local outbreak of pertussis was reported in a rural village (population 1,387) in southwestern China (2). A total of 285 cases were diagnosed. The ages of these patients ranged from 6 months to 80 years; 44% were <7 years of age; and 23% were 15 years of age. No deaths were reported. The suggested cause for this outbreak was relatively low vaccination coverage in the village. The diagnosis of pertussis, especially in patients with atypical symptoms, requires clinicians’ awareness and laboratory tools. To our knowledge, the current laboratory methods (e.g., culture, enzyme immunoassay serologic testing, and polymerase chain reaction assay [PCR]) are not being used to diagnose pertussis in China. In this study, we report six cases of culture-confirmed pertussis in infants seen at Beijing Children’s Hospital. All six patients were initially diagnosed as having other respiratory diseases.

The Study

To determine how much bacterial culturing would aid the diagnosis of pertussis in China, a study was conducted in a 35-bed ward for respiratory diseases at Beijing Children’s Hospital from June 2000 to May 2001. This facility is the largest children’s hospital in China; it has 3,000–4,000 visits daily to its outpatient department. Nasopharyngeal (NP) swabs were taken from children who had been admitted to the hospital because their cough, with or without paroxysms, had persisted for >2 weeks and was worsening. A total of 55 children (age range 35 days to 13 years) were enrolled during the study period. In addition, NP swabs were obtained from two children (ages 10 weeks and 13 years) with paroxysmal cough who were seen at the outpatient department. Information about disease history, immunization status, and cough characteristics was obtained. Physical examination, chest X-ray, and blood tests were performed. At admission, all participants were diagnosed as having bronchitis, bronchopneumonia, or pneumonia. After collection, NP swabs were immediately spread onto charcoal agar plates supplemented with cephalexin. Details of Bordetella pertussis culture have been described previously (3). In brief, after inoculation, the plates were incubated in a humid atmosphere at 35°C and inspected daily for 7 days to determine pertussis-like colony growth. Suspected colonies were Gram stained and tested by slide agglutination with antisera to B. pertussis and B. parapertussis (Murex Diagnostics, Dartford, England). Serum immunoglobulin (Ig) G antibodies to purified pertussis toxin (PT) were tested by enzyme immunoassay, as described (3). Seropositivity was determined by comparing the antibody results in patient serum samples with those in 460 healthy Chinese persons. Results exceeding the mean of the controls by two standard deviations were considered to be seropositive.

Conclusions

Six infants <4 months of age were culture positive for B. pertussis (Table). Five of these patients were in the study group of 55 hospitalized children; the other was one of two children seen at the outpatient department. Before they went to the hospital, all six infants had taken broad-spectrum antibiotics but not erythromycin. None had received any doses of pertussis vaccine.
Table

Clinical details of six infants with pertussis, China, June 2000–May 2001

CaseAge (weeks) and sexDuration of cough at sampling (day)Signs and symptomsLeukocyte count X 109/L
(% lymphocytes)Diagnosis at admissionPossible source of infection
15 (M)15Paroxysmal cough, cyanosis15.3 (62.5)BronchopneumoniaMother, father, grandmothera
29 (F)15Cough without paroxysms19.8 (57.7)BronchopneumoniaCousin
38 (M)15Paroxysmal cough17.6 (63.5)BronchitisNot known
411 (M)15Paroxysmal cough26.7 (52.0)PneumoniaMother, father
516 (M)20Paroxysmal cough, vomiting14.0 (55.0)PneumoniaMother, aunt, cousina
6b10 (M)5Paroxysmal cough27.0 (69.9)BronchitisMother, grandmother

aCulture positive for Bordella pertussis.
bPatient was treated in the outpatient department but not hospitalized.

aCulture positive for Bordella pertussis.
bPatient was treated in the outpatient department but not hospitalized. The immediate family members or other relatives of five infants (cases 1, 2, 4, 5, and 6) had concurrent and persistent cough (Table). NP swabs and serum samples were obtained from family members of cases 1, 5, and 6 (data not shown). Case-patient 1’s grandmother was culture positive for B. pertussis. She, as well as the patient’s mother and father, had been coughing for several weeks, and they all had IgG diagnostic antibodies to PT in their sera. Patient 5’s mother, aunt, and 10-year-old cousin had diagnostic serum IgG antibodies to PT, and another, 8-year-old cousin was culture positive. The grandmother of case-patient 6 had been coughing for 1 month and had diagnostic serum IgG antibodies to PT. Because antigenic divergence, with respect to PT and pertactin (PRN), has been recently found between B. pertussis vaccine strains and circulating strains, the PRN and PT types of eight clinical strains isolated in this study and two vaccine strains were examined. The methods used for this genotyping were LightCycler (Roche Applied Science, Mannheim, Germany) real-time PCR and fluorescence resonance energy transfer hybridization probes (4,5). The two vaccine strains and seven clinical strains harbored prn1, and one clinical strain contained prn2. For PT types, the vaccine strains harbored ptxS1B or ptxS1D, and all clinical strains had ptxS1A. To our knowledge, this is the first report of culture-confirmed pertussis cases from China during the last 30 years. Of the 55 patients hospitalized for persistent cough, 5 (9%) were culture positive for B. pertussis. These results indicate that pertussis is not uncommon in the Chinese population and still causes substantial illness in infants and young children, although the pertussis vaccination coverage for the first three doses is >85% (1). Immunity from immunization wanes with time; thus, older children and adults become susceptible to pertussis (6–8). The role of older children and adults in transmitting B. pertussis to unvaccinated infants has been well documented. More than 80% of hospitalized infants are not the index cases in their families (9). Our results agree with these reports. The family members and other relatives of five infants with culture-confirmed pertussis started to cough first. Evidence of laboratory-confirmed pertussis was obtained from the family members and other relatives of three infants. Although the most serious effects from pertussis occur in young infants (10,11), all six ill infants in our study recovered. Pierce et al. reported 13 critically ill infants with confirmed pertussis, all <3 months of age (11); 4 had leukocyte counts >100 X 109/L; all these infants died. Nine had leukocyte counts <100 X 109/L (11). In the six ill infants in our study, the highest leukocyte count was far lower, 37 X 109/L. However, our six patients had taken antibiotics before consultation. In this study, pertussis was not initially suspected in these ill infants. None had the characteristic whoop. Pertussis at this age group is likely to be atypical, and symptoms resemble those of other respiratory tract infection, apnea, or cyanosis. Consequently, the diagnosis of pertussis is not considered and the treatment is delayed (10). These six infants were initially diagnosed as having bronchitis, bronchopneumonia, or pneumonia. The fact that pertussis was not considered in the differential diagnosis may indicate that clinicians were not aware that B. pertussis was circulating in the community. Early and correct diagnosis of pertussis is important for effective therapy and prevention of transmission of the disease. Culture of B. pertussis from NP samples usually takes 3–7 days. In comparison with culture, PCR is a more sensitive and specific method for diagnosing pertussis (3). Measurement of specific serum antibodies to B. pertussis antigens by enzyme immunoassay can also facilitate this diagnosis, and results are helpful for epidemiologic studies (3,7,12). The use of culture for the diagnosis of pertussis is now being considered in Beijing Children’s Hospital. Our results suggest that a number of pertussis cases are likely being misdiagnosed in China and that the incidence of the diseases is underestimated.
  10 in total

1.  Is leukocytosis a predictor of mortality in severe pertussis infection?

Authors:  C Pierce; N Klein; M Peters
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

2.  Early infantile pertussis; increasingly prevalent and potentially fatal.

Authors:  C Smith; H Vyas
Journal:  Eur J Pediatr       Date:  2000-12       Impact factor: 3.183

3.  Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT).

Authors:  S A Halperin; E E Wang; B Law; E Mills; R Morris; P Déry; M Lebel; N MacDonald; T Jadavji; W Vaudry; D Scheifele; G Delage; P Duclos
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

Review 4.  Epidemiology of pertussis.

Authors:  S Black
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

5.  The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.

Authors:  L A Cattaneo; G W Reed; D H Haase; M J Wills; K M Edwards
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

6.  Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis.

Authors:  Johanna Mäkinen; Jussi Mertsola; Matti K Viljanen; Heikki Arvilommi; Qiushui He
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 7.  Historical review of pertussis and the classical vaccine.

Authors:  J D Cherry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

8.  Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; H Soini; M Skurnik; O Ruuskanen; M K Viljanen
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Outcomes of Bordetella pertussis infection in different age groups of an immunized population.

Authors:  Q He; M K Viljanen; S Nikkari; R Lyytikäinen; J Mertsola
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

10.  Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.

Authors:  J Mäkinen; M K Viljanen; J Mertsola; H Arvilommi; Q He
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

  10 in total
  5 in total

Review 1.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

2.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

3.  Progress in the Diagnosis, Prevention, and Treatment of Pertussis.

Authors:  Flor M. Munoz; Wendy A. Keitel
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

4.  Effect of vaccination on Bordetella pertussis strains, China.

Authors:  Liu Zhang; Yinghua Xu; Jianhong Zhao; Teemu Kallonen; Shenghui Cui; Yunqiang Xu; Qiming Hou; Fengxiang Li; Junzhi Wang; Qiushui He; Shumin Zhang
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

5.  Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).

Authors:  Ying Yang; Kaihu Yao; Xiang Ma; Wei Shi; Lin Yuan; Yonghong Yang
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.